Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor

European Journal of Pharmacology

Volumn 374, Issue 3, 1999, Pages 445-455

  Calandra, Bernard ^a   Portier, Marielle ^a   Kernéis, Aimée ^a   Delpech, Monique ^a   Carillon, Christine ^a   Le Fur, Gérard ^a   Ferrara, Pascual ^a   Shire, David ^a  

^a SANOFI   (France)

Author keywords

Cannabinoid; Cannabinoid CB1 receptor; Cannabinoid CB2 receptor; Chimeric receptor; Cyclic AMP; Luciferase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ADENYLATE CYCLASE; CANNABINOID RECEPTOR; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; LUCIFERASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PERTUSSIS TOXIN; RIMONABANT;

ANIMAL CELL; ARTICLE; CHO CELL; DRUG RECEPTOR BINDING; GENE EXPRESSION SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; SIGNAL TRANSDUCTION;

ANIMALS; BINDING SITES; CANNABINOIDS; CHO CELLS; CORTICOTROPIN-RELEASING HORMONE; CRICETINAE; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; ENZYME INHIBITORS; GENE EXPRESSION; GENES, REPORTER; GTP-BINDING PROTEINS; HUMANS; ISOQUINOLINES; LUCIFERASES; PIPERIDINES; PROTEIN KINASE INHIBITORS; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, DRUG; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SULFONAMIDES;

EID: 0032968566     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00349-0     Document Type: Article

References (53)

1. Allgeier A., Laugwitz K.L., Van Sande J., Schultz G., Dumont J.E. Multiple G-protein coupling of the dog thyrotropin receptor. Mol. Cell. Endocrinol. 127:1997;81-90.
2. Arora K.K., Krsmanovic L.Z., Mores N., O'Farrell H., Catt K.J. Mediation of cyclic AMP signaling by the first intracellular loop of the gonadotropin-releasing hormone receptor. J. Biol. Chem. 273:1998;25581-25586.
3. Bayewitch M., Avidor-Reiss T., Levy R., Barg J., Mechoulam R., Vogel Z. The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling. FEBS Lett. 375:1995;143-147.
4. +-ATPase. Clin. Exp. Hypertension. 20:1998;465-480.
5. Bonhaus D.W., Chang L.K., Kwan J., Martin G.R. Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses. J. Pharmacol. Exp. Ther. 287:1998;884-888.
6. Bouaboula M., Bourrié B., Rinaldi-Carmona M., Shire D., Le Fur G., Casellas P. Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J. Biol. Chem. 270:1995;13973-13980.
7. Bouaboula M., Poinot-Chazel C., Bourrié B., Canat X., Calandra B., Rinaldi-Carmona M., Le Fur G., Casellas P. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem. J. 312:1995;637-641.
8. Bouaboula M., Poinot-Chazel C., Marchand J., Canat X., Bourrié B., Rinaldi-Carmona M., Calandra B., Le Fur G., Casellas P. Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor - involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur. J. Biochem. 237:1996;704-711.
9. Bouaboula M., Perrachon S., Milligan L., Canat X., Rinaldi-Carmona M., Portier M., Barth F., Calandra B., Pecceu F., Lupker J., Maffrand J.P., Le Fur G., Casellas P. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1 - evidence for a new model of receptor/ligand interactions. J. Biol. Chem. 272:1997;22330-22339.
10. 2A-adrenergic receptor to multiple G-proteins. A simple approach for estimating receptor-G-protein coupling efficiency in a transient expression system. J. Biol. Chem. 269:1994;5730-5734.
11. Chakrabarti A., Onaivi E.S., Chaudhuri G. Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein. DNA Sequence. 5:1995;385-388.
12. Childers S.R., Sexton T., Roy M.B. Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem. Pharmacol. 47:1994;711-715.
13. 2-adrenergic receptor to different G proteins by protein kinase A. Nature. 390:1997;88-91.
14. De Groot R.P., den Hertog J., Vandenheede J.R., Goris J., Sassone-Corsi P. Multiple and cooperative events regulate the CREM activator function. EMBO J. 12:1993;3903-3911.
15. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
16. Dittman A.H., Weber J.P., Hinds T.R., Choi E.J., Migeon J.C., Nathanson N.M., Storm D.R. A novel mechanism for coupling of m4-muscarinic acetylcholine receptors to calmodulin-sensitive adenylyl cyclases - crossover from g protein-coupled inhibition to stimulation. Biochemistry. 33:1994;943-951.
17. i coupling. J. Biol. Chem. 270:1995;24753-24760.
18. Eason M.G., Kurose H., Holt B.D., Raymond J.R., Liggett S.B. Simultaneous coupling of α2-adrenoceptors to two G proteins with opposing effects. J. Biol. Chem. 267:1992;15795-15801.
19. Fan F., Tao Q., Abood M., Martin B.R. Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice. Brain Res. 706:1996;13-20.
20. Felder C.C., Veluz J.S., Williams H.L., Briley E.M., Matsuda L.A. Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharmacol. 42:1992;838-845.
21. Felder C.C., Briley E.M., Axelrod J., Simpson J.T., Mackie K., Devane W.A. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. U.S.A. 90:1993;7656-7660.
22. Felder C.C., Joyce K.E., Briley E.M., Glass M., Mackie K.P., Fahey K.J., Cullinan G.J., Hunden D.C., Johnson D.W., Chaney M.O., Koppel G.A., Brownstein M. Ly320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. J. Pharmacol. Exp. Ther. 284:1998;291-297.
23. Fraser C.M., Arakawa S., McCombie W.R., Venter J.C. Cloning, sequence analysis and permanent expression of a human alpha2-adrenergic receptor in Chinese hamster ovary cells. J. Biol. Chem. 264:1989;11754-11761.
24. Gérard C.M., Mollereau C., Vassart G., Parmentier M. Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279:1991;129-134.
25. s linkage to the CB1 receptor. J. Neurosci. 17:1997;5327-5333.
26. Himmler A., Stratowa C., Czernilofsky A.P. Functional testing of human dopamine D1 and D5 receptors expressed in stable cAMP-responsive luciferase reporter cell lines. J. Recept. Res. 15:1993;79-94.
27. Howlett, A.C., 1995. Cannabinoid compounds and signal transduction mechanisms. In: Pertwee, R.G. (Ed.), Cannabinoid Receptors. Academic Press, London, pp. 167-204.
28. Howlett A.C., Song C., Berglund B.A., Wilken G.H., Pigg J.J. Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies. Mol. Pharmacol. 53:1998;504-510.
29. Maneuf Y.P., Brotchie J.M. Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices. Br. J. Pharmacol. 120:1997;1397-1398.
30. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
31. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., Pertwee R.G., Griffin G., Beyewitch M., Barg J., Vogel Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50:1995;83-90.
32. Miloux B., Lupker J.H. Rapid isolation of highly productive recombinant Chinese hamster ovary cell lines. Gene. 149:1994;341-344.
33. Minty A., Chalon P., Guillemot J.C., Kaghad M., Liauzun P., Magazin M., Miloux B., Minty C., Ramond P., Vita N., Lupker J., Shire D., Ferrara P., Caput D. Molecular cloning of the MCP-3 chemokine gene and regulation of its expression. Eur. Cytokine Network. 4:1993;99-110.
34. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
35. s through interaction of α-carboxylic acid of agonist and arginine residue of seventh transmembrane domain. J. Biol. Chem. 270:1995;16122-16127.
36. Okamoto T., Nishimoto I. Detection of G protein-activator regions in m4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure. J. Biol. Chem. 267:1992;8342-8346.
37. Pacheco M.A., Ward S.J., Childers S.R. Differential requirements of sodium for coupling of cannabinoid receptors to adenylyl cyclase in rat brain membranes. J. Neurochem. 62:1994;1773-1782.
38. Pertwee R.G. The central neuropharmacology of psychotropic cannabinoids. Pharmacol. Ther. 36:1988;189-261.
39. Pertwee R.G. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74:1997;129-180.
40. Premont R.T., Matsuoka I., Mattei M.G., Pouille Y., Defer N., Hanoune J. Identification and characterization of a widely expressed form of adenylyl cyclase. J. Biol. Chem. 271:1996;13900-13907.
41. 9-Tetrahydrocannabinol inhibits arachidonic acid acylation of phospholipids and triacylglycerols in guinea pig cerebral cortex slices. Mol. Pharmacol. 40:1991;547-555.
42. Rhee M.H., Bayewitch M., Avidorreiss T., Levy R., Vogel Z. Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes. J. Neurochem. 71:1998;1525-1534.
43. Rinaldi-Carmona M., Barth F., Héaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Néliat G., Caput D., Ferrara P., Soubrié P., Brelière J.-C., Le Fur G. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:1994;240-244.
44. Rinaldi-Carmona M., Barth F., Millan J., Derocq J.M., Casellas P., Congy C., Oustric D., Sarran M., Bouaboula M., Calandra B., Portier M., Shire D., Brelière J.C., Le Fur G. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284:1998;644-650.
45. Shire D., Calandra B., Delpech M., Dumont X., Kaghad M., Le Fur G., Caput D., Ferrara P. Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A. J. Biol. Chem. 271:1996;6941-6946.
46. Shire D., Calandra B., Rinaldi-Carmona M., Oustric D., Pessegue B., Bonnin-Cabanne O., Le Fur G., Caput D., Ferrara P. Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. Biochim. Biophys. Acta Gene Struct. Expression. 1307:1996;132-136.
47. Showalter V.M., Compton D.R., Martin B.R., Abood M.E. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 278:1996;989-999.
48. 35S ]thio]triphosphate binding Proc. Natl. Acad. Sci. U.S.A. 92:1995;7242-7246.
49. 2+ in neuroblastoma×glioma hybrid NG108-15 cells. Biochem. Biophys. Res. Commun. 229:1996;58-64.
50. 2+ transient in NG108-15 cells. J. Biochem. 122:1997;890-895.
51. Sugiura T., Kodaka T., Nakane S., Miyashita T., Kondo S., Suhara Y., Takayama H., Waku K., Seki C., Baba N., Ishima Y. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor - structure-activity relationship of 2-arachidonoylglycerol ether-linked analogues, and related compounds. J. Biol. Chem. 274:1999;2794-2801.
52. Tang W.J., Gilman A.G. Type-specific regulation of adenylyl cyclase by G protein βγ subunits. Science. 254:1998;1500-1503.
53. i2 inhibit cyclic AMP accumulation. Nature. 351:1991;63-65.